↓ Skip to main content

Optimizing the safety of antibody–drug conjugates for patients with solid tumours

Overview of attention for article published in Nature Reviews Clinical Oncology, June 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 2,373)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
2 news outlets
twitter
565 X users
facebook
1 Facebook page

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
130 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Published in
Nature Reviews Clinical Oncology, June 2023
DOI 10.1038/s41571-023-00783-w
Pubmed ID
Authors

Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, Sara M. Tolaney

X Demographics

X Demographics

The data shown below were collected from the profiles of 565 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 130 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 18%
Other 21 16%
Student > Ph. D. Student 12 9%
Student > Postgraduate 12 9%
Student > Doctoral Student 4 3%
Other 12 9%
Unknown 45 35%
Readers by discipline Count As %
Medicine and Dentistry 22 17%
Biochemistry, Genetics and Molecular Biology 21 16%
Chemistry 9 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Agricultural and Biological Sciences 5 4%
Other 17 13%
Unknown 49 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 350. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2024.
All research outputs
#95,667
of 25,980,896 outputs
Outputs from Nature Reviews Clinical Oncology
#15
of 2,373 outputs
Outputs of similar age
#2,204
of 391,077 outputs
Outputs of similar age from Nature Reviews Clinical Oncology
#1
of 41 outputs
Altmetric has tracked 25,980,896 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,373 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 391,077 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.